LEAP THERAPEUTICS INC (LPTX) Top Institutional Shareholders
LEAP THERAPEUTICS INC (LPTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $6.07M in LPTX holdings during the latest filing period.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of LPTX tracked by InsiderSet, reporting ownership valued at approximately $1.86M in its March 31, 2026 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 90% of the total disclosed LPTX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Vanguard Capital Management Llc, Renaissance Technologies LLC, and several other long-term asset managers with concentrated positions in LEAP THERAPEUTICS INC (LPTX).
This page ranks the largest institutional LPTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
39
Total Reported Value
$6.07M
Largest Holder
Blackrock, Inc.
Largest Position
$1.86M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
50
Funds Exiting Positions
0
Frequently asked questions about LPTX
Who owns the most LPTX stock?
The largest holders of LPTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for LEAP THERAPEUTICS INC (LPTX).
Is LPTX widely held by superinvestors?
Many widely followed stocks like LPTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly LPTX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.